Issue #7
Greetings dear reader. By the time you read this, I’ll be gearing to visit the India Health Exhibition in New Delhi, 2026 edition — more on that next week. This week, it’s all about what ‘digitising care’ actually requires on the ground: three deep dives into NABH’s newest standards for patient care, medication management, and continuity of care — plus what KKR’s ₹13,188 Cr bet on Medicover says about what institutional capital is actually looking for in a hospital network.
In the news
Jupiter Hospital performs the world’s first robotic kidney transplants outside China, using MicroPort’s Toumai system
- Jupiter Hospital, Thane successfully performed two consecutive robotic kidney transplants — on patients with end-stage kidney disease, both of whom recovered well — using the CE-certified Toumai robotic surgical system from China’s MicroPort MedBot, a claimed world first outside China. The surgeries were led by senior transplant surgeon Dr. P.P. Rao alongside robotic kidney transplant surgeon Dr. Lokesh Sinha, and mark the 15th year of the hospital’s kidney transplant programme and the 3rd year of its robotic transplant work.
- Why it matters: For a Provider, the lesson isn’t robotic surgery itself — it’s the platform choice. Jupiter Hospital, a mid-tier chain well outside the Apollo/Fortis/Manipal scale, claimed a genuine global first not by outspending the big chains on a da Vinci system, but by adopting an emerging, lower-cost Chinese robotic platform early and building three years of institutional experience with it before this milestone.
- Takeaway: When evaluating new clinical technology, weigh the differentiation upside of being an early, credible adopter of a newer/cheaper platform against the safer path of buying the market leader — and if you go early, treat it as a multi-year capability build (as Jupiter did) rather than a one-off purchase.
Deepinder Goyal’s healthtech startup Temple doubles to $375M valuation, launches its first ESOP buyback
- Temple, the wearable health-tech startup founded by Zomato/Eternal’s Deepinder Goyal after he stepped down as CEO, saw its valuation double to $375 million (from $190 million after a $54 million raise) via a secondary share sale, and used the moment to launch its first ESOP liquidity programme — letting roughly 20 of its ~200-220 employees sell up to 25% of their vested stock options — ahead of a fresh round reportedly being discussed at a $500 million valuation.
- Why it matters: For a Builder, the lesson isn’t the valuation — it’s the sequencing. Goyal explicitly tied the ESOP buyback to a value-creation milestone (“before we close our next round, I want some of this value to reach the people who created it”), turning a funding markup into a retention and morale tool at the moment early employees might otherwise be tempted to leave.
- Takeaway: If your startup has just hit a real value-creation milestone — a funding markup, a profitable quarter, a big contract — look at whether there’s a way, even a small one, to let your earliest employees realise some value now rather than making them wait for a hypothetical future exit.
Lilavati Hospital opens a super-speciality OPD in Kazakhstan — its first international outpost, ahead of a 5,000-bed India/overseas expansion
- Mumbai’s Lilavati Hospital will open a super-speciality outpatient department in Almaty, Kazakhstan in early September 2026 — a consultation-only, referral facility with no inpatient services, covering specialties from oncology to cardiac sciences, with cases needing surgery referred back to Mumbai through an established treatment pathway. It’s the first piece of a broader plan to add roughly 5,000 beds across India (starting with Ahmedabad, Indore and Delhi) and overseas (Kazakhstan, Oman) over the next two years.
- Why it matters: Lilavati is testing an entirely new international market — with real revenue and referral potential — without building a single inpatient bed there first. It’s a low-capital way to establish a country presence and referral pipeline before committing to a full facility — relevant primarily to a Provider, but the underlying logic (test demand cheaply before you build) travels.
- Takeaway: Before committing capital to a new city or country, consider a specialist-consultation-only outpost first — even a weekly visiting-doctor clinic or telehealth desk in that market — to build referral relationships and gauge real demand before you build.
KKR to acquire Medicover’s India hospital business in ₹13,188 Cr ($1.4B) deal
- Global investment firm KKR agreed to acquire the India hospital business of Sweden’s Medicover AB for an enterprise value of roughly €1.2 billion (~₹13,188 crore), buying out Medicover AB’s 66.1% stake and minority partners’ remaining 33.9% for full ownership. Medicover Hospitals operates ~4,700-4,800 beds across 24 hospitals in Telangana, Andhra Pradesh, Karnataka and Maharashtra, generating about €220.5 million in annual revenue (roughly ₹2.75 crore paid per existing bed). The deal is expected to close in Q4 2026, pending regulatory approval.
- Why it matters: For a Provider, this is proof that a well-run, standardised multi-state hospital network — even one built by a relatively low-profile international operator rather than a marquee Indian brand — is exactly what institutional capital is chasing right now. The lesson isn’t the deal size; it’s that consistent quality and a clean, repeatable multi-site operating model, not brand recognition alone, is what makes a hospital network acquisition-ready.
- Takeaway: If long-term consolidation or a strategic sale is even a distant possibility, start now: get governance, financials and clinical protocols standardised to the point that a diligence team could review one facility and trust the rest look the same.
CARPL.ai raises $10M Series A led by IFC to expand its AI radiology marketplace beyond imaging
- CARPL.ai, a startup founded in 2021 by Vidur Mahajan, raised $10 million in a Series A round led by the International Finance Corporation (with Stellaris Venture Partners participating), following a $6 million seed round in 2024. CARPL.ai runs a vendor-neutral platform letting hospitals and imaging centres build, test, deploy and monitor AI applications for radiology — giving customers access to 300+ AI applications from 100+ partners through a single integration — and plans to use the funding to expand into pathology, genomics and general medicine, and to grow commercially across North America, Latin America, Europe, APAC and emerging markets.
- Why it matters: CARPL.ai didn’t build its own AI diagnostic models — it built the integration layer that lets hospitals adopt everyone else’s models without a separate procurement and IT project for each one. For a Builder, that’s a reminder that the highest-leverage product in a fragmented, fast-moving category isn’t always the flashiest point solution — sometimes it’s the plumbing that makes every other vendor’s product usable.
- Takeaway: If you’re building point solutions in a category with many competing vendors, ask whether hospitals’ real bottleneck is a specific capability gap or the integration/procurement overhead of adopting multiple tools — the second problem is often less crowded and stickier to solve.
Popular on A|P this week
Insights to help you grow and optimise your healthcare business.
NABH Digital Health Standard for Hospital’s COP Chapter Explained: Digitising Care of Patients
- COP is the one chapter in the whole standard where the case for early action can’t come from a Core mandate — because it has none. A hospital can reach Silver tier having done nothing in COP at all. That makes it easy to treat as optional. But a hospital that deprioritises COP because “nothing here is Core” is optimising for the short term, and that may be fine as a deliberate call but it should know COP is where its digital maturity will get seriously tested.
- Takeaway: A patient handed off between departments, transferred from an ambulance to an ED, or whose blood type needs to move from a blood bank record to an OT team in minutes, will benefit immensely from COP maturity.
NABH Digital Health Standard for Hospital’s MOM Chapter Explained: Digital Medication Management and the 6R Framework
- MOM is a very important chapter and Digital Standard eligibility requires 100% adherence to it. A hospital cannot defer emergency medication tracking as a “later phase” of its digital maturity plan — it is part of the floor every tier is built on, not an advanced capability reserved for Gold or Platinum.
- Takeaway: Check whether your HMIS actually enforces the checks that prevent a wrong-patient or wrong-dose error, and whether the hospital’s emergency medication stock is tracked with the same discipline as its routine formulary, not treated as the one drawer no system watches.
NABH Digital Standard for Hospital’s AAC Chapter Explained: What Digital Access, Assessment and Continuity of Care Requires
- A hospital cannot obtain NABH Digital Health Standard accreditation while treating AAC as a chapter to revisit later; a majority of its Commitment elements have to be in place from the first assessment.
- Takeaway: The question AAC actually asks isn’t whether a hospital has a reception desk, a lab, and a discharge process — every hospital does. It’s whether those processes run on a digital system that generates one identity per patient and links every downstream record to it, or whether that link still lives in a filing cabinet and a receptionist’s memory.
You are receiving this newsletter because you are on the mailing list of Aviral Prakash. If you would like to unsubscribe / update your e-mail address or provide feedback on how this newsletter can be made better please write to info@aviralprakash.com
Copyright ©️ 2026 | Aviral Prakash